Teladoc Health, Inc. (TDOC)
NYSE: TDOC · Real-Time Price · USD
9.44
+0.47 (5.24%)
At close: Dec 20, 2024, 4:00 PM
9.48
+0.04 (0.42%)
After-hours: Dec 20, 2024, 7:52 PM EST
Teladoc Health Stock Forecast
Stock Price Forecast
The 19 analysts with 12-month price forecasts for Teladoc Health stock have an average target of 12.24, with a low estimate of 8.00 and a high estimate of 19. The average target predicts an increase of 29.66% from the current stock price of 9.44.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Teladoc Health stock from 20 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 14 | 13 | 13 | 13 | 13 | 13 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 19 | 19 | 19 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $11 → $13 | Buy | Reiterates | $11 → $13 | +37.71% | Dec 4, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $14 | Strong Buy | Initiates | $14 | +48.31% | Nov 15, 2024 |
| Deutsche Bank | Deutsche Bank | Hold Maintains $10 → $12 | Hold | Maintains | $10 → $12 | +27.12% | Nov 1, 2024 |
| Barclays | Barclays | Buy Maintains $10 → $12 | Buy | Maintains | $10 → $12 | +27.12% | Oct 31, 2024 |
| TD Cowen | TD Cowen | Hold Maintains $9 → $8 | Hold | Maintains | $9 → $8 | -15.25% | Oct 31, 2024 |
Financial Forecast
Revenue This Year
2.62B
from 2.60B
Increased by 0.68%
Revenue Next Year
2.59B
from 2.62B
Decreased by -1.03%
EPS This Year
-5.93
from -1.34
EPS Next Year
-0.88
from -5.93
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 2.7B | 2.7B | 2.8B | |||
| Avg | 2.6B | 2.6B | 2.6B | |||
| Low | 2.5B | 2.4B | 2.4B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 5.0% | 4.5% | 7.7% | |||
| Avg | 0.7% | -1.0% | 2.0% | |||
| Low | -3.7% | -8.1% | -5.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -5.90 | -0.22 | 1.32 | ||
| Avg | -5.93 | -0.88 | -0.64 | ||
| Low | -5.80 | -1.28 | -1.20 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.